Figure 2

An HIV-infected patient with mucocutaneous leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS). In May 2009, five months after the initiation of HAART therapy, he presented with ulcerative lesions on his face in association with nasal obstruction. A and B: By August 2009, the lesions progressed and severe inflammation with pronounced swelling of the lips, nasal and mentum regions are pictured. C: Computerized tomography of the paranasal sinus cavities shows partial destruction of the nasal septum (white arrow) (August, 2009). D: Healing of lesions observed following treatment with Prednisolone and Amphotericin B (September 2009).